KAM

Krensavage Asset Management Portfolio holdings

AUM $189M
1-Year Est. Return 19.71%
This Quarter Est. Return
1 Year Est. Return
+19.71%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$189M
AUM Growth
+$8.05M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
16
New
Increased
Reduced
Closed

Top Buys

1
+$6.8M
2
+$6.11M
3
+$2.1M
4
VNDA icon
Vanda Pharmaceuticals
VNDA
+$1.28M
5
SUPN icon
Supernus Pharmaceuticals
SUPN
+$1.27M

Top Sells

1
+$17M
2
+$9.24M
3
+$1.51M
4
MURA icon
Mural Oncology
MURA
+$89K
5
ENTA icon
Enanta Pharmaceuticals
ENTA
+$16.2K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$19B
$29.1M 15.38%
101,146
+2,918
CAH icon
2
Cardinal Health
CAH
$38.9B
$22.5M 11.89%
133,745
-55,000
EXEL icon
3
Exelixis
EXEL
$10.8B
$21.8M 11.51%
493,526
-385,007
JAZZ icon
4
Jazz Pharmaceuticals
JAZZ
$8.45B
$17.5M 9.26%
164,816
+64,113
ENTA icon
5
Enanta Pharmaceuticals
ENTA
$303M
$16M 8.46%
2,114,444
-2,142
SUPN icon
6
Supernus Pharmaceuticals
SUPN
$2.96B
$14.9M 7.88%
472,376
+40,390
INDV icon
7
Indivior
INDV
$3.09B
$14.4M 7.6%
974,474
+9,106
GSK icon
8
GSK
GSK
$88B
$10.4M 5.52%
271,729
-271
AVDL
9
Avadel Pharmaceuticals
AVDL
$1.81B
$8.49M 4.49%
958,877
+8,877
BNTX icon
10
BioNTech
BNTX
$25.5B
$7.81M 4.14%
73,382
-14,181
SNY icon
11
Sanofi
SNY
$125B
$7.2M 3.81%
148,946
-150
JNJ icon
12
Johnson & Johnson
JNJ
$458B
$6.11M 3.23%
+40,000
ALKS icon
13
Alkermes
ALKS
$4.91B
$5.95M 3.15%
207,822
VNDA icon
14
Vanda Pharmaceuticals
VNDA
$331M
$4.84M 2.56%
1,024,883
+270,502
REGN icon
15
Regeneron Pharmaceuticals
REGN
$62B
$2.1M 1.11%
+4,000
MURA icon
16
Mural Oncology
MURA
$36.4M
– –
-70,263